StockCIK 822370

Emmaus Life Sciences, Inc. (EMMA): Insider Trades and Fund Holdings

In the past 12 months, Emmaus Life Sciences, Inc. insiders reported 6 open-market purchases worth $18K and 0 sales worth $0.

6Insider buys, 12 months

$18KBought by insiders, 12 months

$0Sold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 2, 2026.

Recent EMMA insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 2	Aug 28	Willis C. LeeCEO	CEO (ind.)	▲ BUY	94,767	0.06	$6K	+19%	Form 4 ↗
Sep 2	Aug 31	Willis C. LeeCEO	CEO (ind.)	▲ BUY	100,000	0.05	$5K	+17%	Form 4 ↗
Sep 2	Aug 27	Willis C. LeeCEO	CEO (ind.)	▲ BUY	50,000	0.05	$3K	+11%	Form 4 ↗
Sep 2	Aug 25	Willis C. LeeCEO	CEO (ind.)	▲ BUY	46,000	0.04	$2K	+12%	Form 4 ↗
Sep 2	Aug 29	Willis C. LeeCEO	CEO (ind.)	▲ BUY	170,000	0.01	$2K	+161%	Form 4 ↗
Sep 2	May 30	Willis C. LeeCEO	CEO (ind.)	▲ BUY	70,000	0.02	$1K	+44%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Willis C. Lee	CEO	6	$18K	0	$0	Sep 2, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →